Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited ( (AU:FRE) ) has provided an update.
Firebrick Pharma Limited has announced the withdrawal of its proposed share placement, a decision made by the company’s board. This move may affect the company’s financial strategy and market positioning, as it continues to focus on expanding the reach of its Nasodine® Nasal Spray and other products.
More about Firebrick Pharma Limited
Firebrick Pharma is a pharmaceutical innovator focused on developing and commercializing novel formulations and uses of povidone-iodine (PVP-I). The company has developed Nasodine® Nasal Spray and is expanding its market presence in the United States, Singapore, Fiji, the South Pacific, and the Philippines.
Average Trading Volume: 65,849
Technical Sentiment Signal: Sell
For a thorough assessment of FRE stock, go to TipRanks’ Stock Analysis page.